Personalized Drug Regimen Helps High-Risk Patient Clear Resistant Tuberculosis
A 60-year-old man in India with rifampicin-resistant tuberculosis and severe coexisting illnesses has completed an 18-month individualized treatment course and ...
Tag: difficult-to-treat
